| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/20/1999 | EP0891984A2 Nucleic acid encoding streptococcus pneumoniae response regulator |
| 01/20/1999 | EP0891982A2 HIV peptides |
| 01/20/1999 | EP0891551A1 Protein phosphatase-1 catalytic subunit interactions |
| 01/20/1999 | EP0891547A1 $i(IN VITRO) ASSAY FOR IDENTIFICATION OF CARCINOGENS |
| 01/20/1999 | EP0891429A2 Recombinant aav vector-based transduction system and use of same |
| 01/20/1999 | EP0891427A1 Expression of hgv antigens and their use |
| 01/20/1999 | EP0891426A2 Human bikunin |
| 01/20/1999 | EP0891425A2 Methods and compositions for regulating t cell subsets by modulating transcription factor activity |
| 01/20/1999 | EP0891424A1 Human cachexia associated protein |
| 01/20/1999 | EP0891378A1 Use of a pharmaceutical composition comprising an appetite-suppressing peptide |
| 01/20/1999 | EP0891377A1 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 01/20/1999 | EP0891374A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 01/20/1999 | EP0891372A1 Growth factor htter36 |
| 01/20/1999 | EP0792288B1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 01/20/1999 | EP0759986B1 Diagnostics for cancers expressing tyrosine phosphorylated crkl protein |
| 01/20/1999 | EP0734450B1 Methods for controlling sialic acid derivatives in recombinant glycoproteins |
| 01/20/1999 | EP0668877B1 Displacement chromatography process and purified hemoglobin product |
| 01/20/1999 | EP0656908B1 Use of specific binding molecules in potentiating igf-i activity |
| 01/20/1999 | EP0647271B1 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 01/20/1999 | EP0613496B1 Collagen-like polypeptides |
| 01/20/1999 | EP0597960B1 Treatment of cell populations |
| 01/20/1999 | EP0445228B1 Immunotherapy involving cd28 stimulation |
| 01/20/1999 | CN1205741A Prodn. of recombinant baculoviruses |
| 01/20/1999 | CN1205739A Antimicrobial proteins |
| 01/20/1999 | CN1205738A OB protein derivatives having prolonged half-life |
| 01/20/1999 | CN1205708A Method of mobilizing hematopoietic stem cells |
| 01/20/1999 | CN1205613A Hybrid matrix implants and explants |
| 01/20/1999 | CN1205350A Protein high molecular dye |
| 01/19/1999 | US5861543 Dna and amino acid sequences encoding a protein; plant cells such as corn transformed by the dna to be resistant to lepidopteran insects |
| 01/19/1999 | US5861542 Gene controlling floral development and apical dominance in plants |
| 01/19/1999 | US5861500 Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin 6 (IL-6) and uses thereof |
| 01/19/1999 | US5861499 Nucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domain |
| 01/19/1999 | US5861498 Genetic engineering and nucleic acid molecules and coding proteins |
| 01/19/1999 | US5861497 Trabecular meshwork induced glucocorticoid response (TIGR) nucleic acid molecules |
| 01/19/1999 | US5861495 Human zinc binding proteins |
| 01/19/1999 | US5861494 Utilizing polynucleotides or polypeptides as a diagnostic marker for colon cancer |
| 01/19/1999 | US5861491 Isolation of lactoferrin from milk |
| 01/19/1999 | US5861490 Cd8 suppressor molecule, fractionation of media and identification of fractions |
| 01/19/1999 | US5861488 Gene therapy and gene expression of antisickling globulin proteins |
| 01/19/1999 | US5861486 Collagen modulators for use in photoablation eximer laser keratectomy |
| 01/19/1999 | US5861485 Polypeptides involved in body weight disorders, including obesity |
| 01/19/1999 | US5861484 Treatment of psoriasis, rheumatoid arthritis, hemangiomas, angiofibromas, diabetic retinopathy, neovascular glaucoma,and other vegf-induced pathological angiogenesis and vascular permeability conditions, such as tumor vascularization |
| 01/19/1999 | US5861483 Inhibitor of stem cell proliferation and uses thereof |
| 01/19/1999 | US5861482 Genetic mapping |
| 01/19/1999 | US5861480 Capable of isolation from seeds of aralia or impatiens exhibit antifungal and antibacterial activity |
| 01/19/1999 | US5861479 Genetic engineering with dna and amino acid sequences |
| 01/19/1999 | US5861478 Lytic peptides |
| 01/19/1999 | US5861477 Cyclic peptide catalysts modeled on enzyme active sites |
| 01/19/1999 | US5861476 Peptides and compounds that bind to the IL-1 receptor |
| 01/19/1999 | US5861475 Compositions and methods for the inhibition of phagocytes |
| 01/19/1999 | US5861381 Pharmaceutical composition for the treatment of a malignant tumor |
| 01/19/1999 | US5861379 Chimeric fatty body-pro-GRF analogs with increased biological potency |
| 01/19/1999 | US5861378 Polypeptides having specified amino acid sequences; antiseptics, effective against grampositive and gramnegative bacteria |
| 01/19/1999 | US5861377 Antistasin type serine protease inhibitors |
| 01/19/1999 | US5861376 Synthetically derived peptide |
| 01/19/1999 | US5861314 Genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (aav) material for genomes |
| 01/19/1999 | US5861312 Recognition component; hybridization; dna expression vectors; genetic engineering |
| 01/19/1999 | US5861310 Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor |
| 01/19/1999 | US5861309 Amino acid sequences encoding it, vectors for its expression in yeast, bacterial, and mammalian cells; research into the characterization of the pharmacology of individual human alpha 1 receptor subtypes |
| 01/19/1999 | US5861308 Isolated nucleic acids associated with T cell activation and uses thereof |
| 01/19/1999 | US5861307 Liposomes embedded with dna; antitumor agents; apotosis |
| 01/19/1999 | US5861299 Genetic construct of which protein coding DNA comprises introns and is designed for protein production in transgenic animals |
| 01/19/1999 | US5861297 Detergent-free hepatitis C protease |
| 01/19/1999 | US5861290 Methods and polynucleotide constructs for treating host cells for infection or hyperproliferative disorders |
| 01/19/1999 | US5861285 Fusion dna sequence, obtained by fusing a gene coding for another useful protein to a fragment of a maga gene coding for a protein bound to an organic membrane for covering magnetic particles produced in cells of a magnetic bacterium amb-1 |
| 01/19/1999 | US5861284 Method for producing a biologically active recombinant cysteine-free parathyroid hormone (1-34) |
| 01/19/1999 | US5861283 DNA encoding a limbic system-associated membrane protein |
| 01/19/1999 | US5861282 Mutant constructs; vaccines; genetic engineering |
| 01/19/1999 | US5861279 Using peanut agglutinin as lectin in scintillation proximity assay |
| 01/19/1999 | US5861278 HNF3δ compositions |
| 01/19/1999 | US5861275 Lantibiotic mutants and chimeras of enhanced stability and activity, leader sequences therefor, genes encoding the same, and methods of producing and using the same |
| 01/19/1999 | US5861274 Nucleic acids encoding peroxisome proliferator-activated receptor |
| 01/19/1999 | US5861273 Inserting a copy of a gene encoding the heterologous protein of interest into the chromosome of a host cell |
| 01/19/1999 | US5861272 Antiasthmatic, antiallergen, and antiinflammatory agents;genetic engineering |
| 01/19/1999 | US5861267 Methods, nucleotide sequences and host cells for assaying exogenous and endogenous protease activity |
| 01/19/1999 | US5861266 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 01/19/1999 | US5861260 Contacting sample from patient with a pure centrosomal protein cp140 polypeptide fragment so that it will bind to autoantibodies, detecting autoantibody:cp140 complexes, if present, indicates disease |
| 01/19/1999 | US5861259 Immunoassays for human cyclin E |
| 01/19/1999 | US5861258 Use of the alpha interferon receptor and cells which express the receptor, for identification of alpha interferon agonists |
| 01/19/1999 | US5861257 Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications |
| 01/19/1999 | US5861255 Performing polymerase chain reaction of dna using primer oligonucleotides, annealing and treatment with actinobacillus |
| 01/19/1999 | US5861250 Protecting nucleic acids and methods of analysis |
| 01/19/1999 | US5861248 Biomarkers for detection of prostate cancer |
| 01/19/1999 | US5861243 Amino acid sequences |
| 01/19/1999 | US5861240 Isolated human herpesvirus type 8 sequences and uses thereof |
| 01/19/1999 | US5861239 Treating cells having tub genes(body weight controllers) with test compounds to determine if they change the reactions of the tub protein; drug screening, obesity therapy |
| 01/19/1999 | US5861238 Methods for partitioning advanced glycosylation endproducts |
| 01/19/1999 | US5861171 Adeno-associated viral (AAV) liposomes and methods related thereto |
| 01/19/1999 | US5861164 Vaccination against diseases resulting from pathogenic responses by specific T cell populations |
| 01/19/1999 | US5861163 Immunnology and cells |
| 01/19/1999 | US5861161 Chimeric proteins comprising a Vpr/Vpx virion incorporation domain for targeting into HIV-1 or HIV-2 virions |
| 01/19/1999 | US5861160 Vaccines for swine; epitope amino acid sequences; genetic engineering |
| 01/19/1999 | US5861157 An immunogenic fragment obtained from a bacterial protein capable of eliciting antibody response |
| 01/19/1999 | US5861151 Soluble fusion molecules with binding specificity for cell adhesion molecules |
| 01/19/1999 | US5861150 Recombinant human CSF-1 dimer and compositions thereof |
| 01/19/1999 | US5861139 Method and composition for labeling proteins, peptides and amino acids, including antibodies, with a variety of metals ions (tin), including radioisotopes |
| 01/19/1999 | CA2139552C Use of self-incompatibility receptor proteins (slg and srk) of plants for the treatment of allergic diseases |
| 01/19/1999 | CA2105382C Recombinant hybrid porin epitopes |
| 01/19/1999 | CA2067748C Dye transfer inhibition |
| 01/19/1999 | CA2025900C Derivative of tissue-type plasminogen activator |